Curai Health
Published in

Curai Health

Curai’s Medical Advisory Board

At Curai we take our mission of “Providing the world’s best healthcare to everyone” to heart. This means our company must be informed by the best medical expertise. We have an amazing group of doctors on our team. In addition, we believe that receiving input from independent experts from outside the company is important to ensure we are aligned with leaders in clinical innovation. That is why we favor publishing our research in peer-reviewed publications and why we are announcing our Medical Advisory Board today.

We are ecstatic to have attracted such a diverse group of world-class medical experts in a broad range of subjects, including clinical safety/quality, population health, bioinformatics, and the business of healthcare. This group has already given us perspectives that have informed our medical and technical approaches. We look forward to working with our medical advisors , and to them providing an independent expert perspective on Curai’s efforts. We expect the advisory board will help us stay abreast of clinical, industry, and technological developments, and work through ethical questions in line with our statement of ethical commitment and intent.

Curai’s mission

Without further ado, our initial Medical Advisory Board is composed of the following medical experts:

  • Dr. Tejal Gandhi, Chief Safety and Transformation Officer, Press Ganey Associates LLC
  • Dr. Mark L Graber, Founder and President Emeritus, Society to Improve Diagnosis in Medicine (SIDM), Professor Emeritus, Stony Brook University, NY
  • Dr. Rainu Kaushal, Senior Associate Dean, Clinical Research. Chair, Department Population Health Sciences, Weill Cornell Medicine
  • Dr. Harold Paz, Executive Vice President and Chancellor for Health Affairs, The Ohio State University and Chief Executive Officer, Ohio State Wexner Medical Center
  • Dr. Nigam Shah, Professor of Medicine, and Biomedical Data Science. Stanford University
  • Dr. Robert Wachter, Professor and Chair, Department of Medicine, University of California, San Francisco

Here you can read a bit about their amazing prior accomplishments:

— — — — — — —

Dr.Tejal Gandhi

Chief Safety and Transformation Officer, Press Ganey Associates LLC

Tejal Gandhi, MD, MPH, CPPS, is the Chief Safety and Transformation Officer at Press Ganey. In this role, Dr. Gandhi is responsible for advancing the Zero Harm movement, improving patient and workforce safety, and developing innovative health care transformation strategies. In addition, Dr. Gandhi is leading the Press Ganey Equity Partnership to advance equity in health care. Before joining Press Ganey, Dr. Gandhi served as Chief Clinical and Safety Officer at the Institute for Healthcare Improvement (IHI), where she led IHI programs focusing on improving patient and workforce safety. Prior to this, Dr. Gandhi was President and Chief Executive Officer of the National Patient Safety Foundation (NPSF) from 2013 until 2017, when NPSF merged with IHI.

In 2019, Dr. Gandhi was elected as a member of the National Academy of Medicine. She is a recipient of the John M. Eisenberg Patient Safety and Quality Award, given in recognition of her contributions to understanding the epidemiology of medical errors in the outpatient setting and for developing prevention strategies. Dr. Gandhi has also been named as one of the “100 Most Influential People in Healthcare,” “Top 25 Women in Healthcare,” and “50 Most Influential Clinical Executives” by Modern Healthcare magazine.

— — — — — — -

Dr. Mark L Graber

Founder and President Emeritus, Society to Improve Diagnosis in Medicine (SIDM). Professor Emeritus, Stony Brook University, NY

Mark L. Graber, MD, FACP is Professor Emeritus of Medicine at Stony Brook University, NY and the Founder and President Emeritus of the Society to Improve Diagnosis in Medicine.

Dr Graber is a national leader in the field of patient safety. With Ilene Corina, he started the Patient Safety Awareness Week in 2002, an event now recognized internationally. In 2014 he received the John M Eisenberg Award, the nation’s top honor in patient safety and quality.

He is a pioneer in efforts to address diagnostic errors in medicine. In 2008 he originated the Diagnostic Error in Medicine conference series, in 2011 he founded the Society to Improve Diagnosis in Medicine (, and in 2014 he launched a new journal, DIAGNOSIS, devoted to improving the quality and safety of diagnosis, and reducing diagnostic error.

— — — — — — —

Dr. Rainu Kaushal

Senior Associate Dean, Clinical Research Chair, Department Population Health Sciences. Weill Cornell Medicine

Rainu Kaushal, MD, MPH, is the Senior Associate Dean for Clinical Research, Chair of the Department of Population Health Sciences, and Nanette Laitman Distinguished Professor at Weill Cornell Medicine; and the Physician-in-Chief of Population Health Sciences at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

A distinguished information scientist and health services researcher, Dr. Kaushal leads Weill Cornell Medicine’s clinical research enterprise, bridging cutting-edge science with patient care.

Dr. Kaushal has made significant contributions to pediatric patient safety, health information technology, and value-based healthcare delivery. She has led several key studies on interoperable health information technology, and serves as the principal investigator of INSIGHT Clinical Research Network, the country’s largest urban clinical database of 22 million patients.

Dr. Kaushal is also a committed educator. She has established four master’s programs, including a joint Executive MBA/MS in Healthcare Leadership with the Cornell SC Johnson College of Business, a doctoral program, and a research fellowship with 200 students matriculating annually.

An author of over 200 papers in various scientific publications, Dr. Kaushal is a frequently invited speaker at national and international meetings. She also serves on multiple boards and advisory committees and is an elected member of the National Academy of Medicine.

— — — — — — -

Dr. Harold Paz

Executive Vice President and Chancellor for Health Affairs, The Ohio State University and Chief Executive Officer, Ohio State Wexner Medical Center

Dr. Harold L. Paz is executive vice president and chancellor for health affairs at The Ohio State University and chief executive officer of the Ohio State Wexner Medical Center. At Ohio State, Dr. Paz leads all seven health science colleges and serves as CEO of the over $4-billion Wexner Medical Center enterprise, which includes seven hospitals, a nationally ranked college of medicine, over 20 research institutes, multiple ambulatory care sites, over 2,500 clinicians and an accountable care organization, and a health plan.

Before joining OSU in June 2019, Dr. Paz was executive vice president and chief medical officer at CVSHealth/Aetna where he led clinical strategy and policy at the intersection of all of Aetna’s domestic and global businesses. He reported to Aetna’s chairman and CEO and was a member of its executive committee. Prior to joining Aetna in 2014, Dr. Paz served as president and CEO of the Penn State Hershey Health System, senior vice president for health affairs at the Pennsylvania State University, and dean of its College of Medicine for eight years. Before his appointment at Penn State, he spent eleven years as dean of the Robert Wood Johnson Medical School and CEO of the Robert Wood Johnson University Medical Group.

Dr. Paz received his bachelor’s degree from the University of Rochester, a master of science in life science engineering from Tufts University, and his medical degree from the University of Rochester School of Medicine and Dentistry. He completed his residency at Northwestern University, where he served as chief medical resident. Dr. Paz was a Eudowood Fellow in pulmonary and critical care medicine at Johns Hopkins Medical School. In addition, he was a post-doctoral fellow in environmental health science at Johns Hopkins School of Hygiene and Public Health.

— — — — — — -

Dr. Nigam Shah

Professor of Medicine, and Biomedical Data Science. Stanford University

Dr. Nigam Shah is Professor of Medicine (Biomedical Informatics) at Stanford University, and serves as the Associate CIO for Data Science for Stanford Health Care. Dr. Shah’s research focuses on bringing machine learning to clinical use safely, ethically and cost-effectively. Dr. Shah was elected into the American College of Medical Informatics (ACMI) in 2015 and was inducted into the American Society for Clinical Investigation (ASCI) in 2016. He holds an MBBS from Baroda Medical College, India, a PhD from Penn State University and completed postdoctoral training at Stanford University.

— — — — — — —

Dr. Robert Wachter

Professor and Chair, Department of Medicine, University of California, San Francisco

Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF). In 2021–22, the Department was ranked the best internal medicine department in the nation by U.S. News & World Report. Wachter is author of 300 articles and 6 books. He coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest growing medical specialty in the U.S. history. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine. He has written two books on safety and quality. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine’s Computer Age, was a New York Times science bestseller.

He has received several honors for his work. In 2004, he received the John M. Eisenberg Award, the nation’s top honor in patient safety. Thirteen times, Modern Healthcare magazine has ranked him as one of the 50 most influential physician-executives in the U.S.; he was #1 on the list in 2015. He is a Master of the American College of Physicians and an elected member of the National Academy of Medicine. In 2020–21, his tweets on Covid-19 were viewed over 150 million times by 170,000 followers and served as a trusted source of information on the clinical, public health, and policy issues surrounding the pandemic. He is currently serving as the interim host of the Covid-19 podcast “In the Bubble,” which is downloaded about 1 million times each month.




Applying AI/ML to improve access, efficiency, and outcomes for primary health care

Recommended from Medium

Lies, damn lies and (vaping) statistics

Tuberculosis: The Unromantic Challenges in Diagnostics and Treatment

Heart disease and cancer — what links two of the world’s most deadly diseases?

Scaling Up Covid-19 Vaccines — from Laboratory R&D to High-Volume Production

Stuck in the Middle with Me

Types of Healthcare Apps and What You Need to Remember when Developing One

Low Estrogen Symptoms: Signs to Watch For & What Can You Do About It!

What is COVID-19, REALLY?

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Xavier Amatriain

Xavier Amatriain

Cofounder/CTO at Curai (AI for healthcare). Former Quora VP, Netflix Director. Software, Machine Learning, Data, Recsys... From Barcelona, in the Valley

More from Medium

The Deep Future is Now.

10 Questions w/ Widya Mulyasasmita — Senior Principal @ B Capital Group

A financial argument for deep tech

Artificial Intelligence Company Applied XL Raises $3.5 million led by Hearst Ventures